Summary of "Weekly Meeting Oct 9 2025"
Summary of Weekly Meeting Oct 9, 2025
Company Strategy & Operations
Mass Tort Lawsuit Initiative
- The company is actively encouraging patients to join a mass tort lawsuit related to the opioid crisis.
- The lawsuit is positioned as the primary effective tool to combat opioid-related deaths, given governmental agencies (CDC, HHS, FDA) are seen as ineffective or part of the problem.
- Target group: survivors of opioid addiction (estimated 8-9 million affected, with over 4 million deceased).
- Call to action: Patients are urged to sign up and engage, with direct contact options (cell phone, email) provided by leadership.
- Moral framing emphasizes collective responsibility:
“Are we our brother’s keepers?” The bravery of participants is commended.
Educational Content & Communication
- Launching a book titled “The Pharmaceutical Genocide: The Open Opioid Poisoning Exposed” as a key educational and advocacy tool.
- The book aims to clarify legal standing and strengthen the mass tort case.
- Weekly podcasts (Monday–Thursday, 2:30 PM) provide scientific updates and ongoing education.
- Leadership encourages feedback and interaction regarding the book cover and content.
Product & Process: Drug Screening Program
Drug Screen Submission Requirements & AI Integration
- Drug screens must include:
- A dated test (date must be written directly on the test, not on a note or next to it).
- Patient’s name on the test.
- Patient’s valid photo ID (driver’s license) clearly visible in the submission photo.
- Starting November 1, the AI system will automatically reject any drug screen submissions missing these elements.
- The AI compares new submissions to previous ones to detect duplicates or fraud, marking identical tests with visual alerts for manual review.
- Compliance is critical to avoid delays or rejection of prescriptions.
Test Types & Logistics
- Standard test: 6-panel drug screen including:
- BUP (buprenorphine)
- Benzo (benzodiazepines)
- COC (cocaine)
- MOP (morphine/opioids)
- MTD (methadone)
- OX (oxycodone)
- 12-panel tests are available but not stocked by the company; patients must procure these independently if needed.
- 12-panel tests often ship faster than 6-panel tests on Amazon.
- The company offers to ship 6-panel tests directly to patients (primarily in Florida, North Carolina, Tennessee) with 3-day ground shipping and tracking.
- Payment for shipped tests is via Cash App, integrated directly with the postage system for efficiency.
- Leadership encourages patients to reach out if financial hardship prevents obtaining tests; assistance will be provided.
Management & Leadership
Patient Advocacy & Support
- Susie Burming, Managing Director and pastor, emphasizes her dual role as manager and patient advocate.
- She maintains open communication channels and offers emotional and spiritual support to patients.
- Patients are encouraged to be proactive champions of their own care while assured of ongoing company support.
- Successes highlighted include couples recovering together and healthy births, reinforcing program impact since 2018.
Community Building & Engagement
- The company fosters a supportive patient community via a Facebook group and regular communications.
- Leadership promotes positivity, mutual support, and “paying it forward” as core cultural values.
- Regular reminders encourage patients to stay on track with their recovery and compliance.
Key Frameworks, Processes & Playbooks
-
Mass Tort Lawsuit Strategy Positioning legal action as a primary lever for systemic change, supported by educational materials (book, podcasts) and direct patient engagement.
-
AI-Enabled Compliance Monitoring Automated verification of drug screens to ensure accuracy and prevent fraud, with clear submission guidelines communicated to patients.
-
Patient Support & Retention Multi-channel support (phone, email, text, social media), emotional/spiritual care integrated with clinical management, and financial assistance for compliance-related costs.
Metrics & Targets
- No explicit numeric KPIs or financial targets were mentioned.
- Timeline: AI enforcement of drug screen submission rules begins November 1, 2025.
- Program longevity: Operating since 2018 with ongoing patient recovery success stories.
Actionable Recommendations
For Patients
- Join the mass tort lawsuit by contacting leadership directly.
- Read and provide feedback on the upcoming book to strengthen advocacy.
- Submit drug screens strictly following the new AI-compliance guidelines to avoid rejection.
- Reach out proactively for financial or emotional support if needed.
- Engage with community resources (podcasts, Facebook group) for education and encouragement.
For Staff
- Continue promoting the mass tort initiative and educational content.
- Monitor AI reports on drug screen submissions and provide timely feedback.
- Facilitate logistics for shipping drug tests efficiently.
Presenters & Sources
- Susie Burming – Managing Director, Patient Advocate, and Pastor
- Dr. Smith – Medical Expert and Legal Advocate for Mass Tort Lawsuit
This summary focuses on the business execution aspects of patient management, legal strategy, product/process compliance, and leadership engagement highlighted in the meeting.
Category
Business
Share this summary
Is the summary off?
If you think the summary is inaccurate, you can reprocess it with the latest model.
Preparing reprocess...